Home / Stocks / ACRV

ACRV insider trading

Acrivon Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$115k
Buys · last 90 days
0 · $0
Most recent buy
2026-01-16

Cluster buy detected

3 insiders bought ACRV within a short window (2026-01-13→2026-01-14), $115k in total — cluster score 58/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-16Masson Kristinacluster
EVP - Business Operations
Bought49,000$1.68$82k
2026-01-16Levy Adam D.cluster
Chief Financial Officer
Bought8,832$1.70$15k
2026-01-15Devroe Ericcluster
Chief Operating Officer
Bought10,000$1.72$17k
2025-04-29EDELMAN JOSEPH
10% owner
Sold1,054,669$1.95$2.1M

Most active insider buyers

InsiderRoleBuysTotal bought
Masson KristinaEVP - Business Operations1$82k
Devroe EricChief Operating Officer1$17k
Levy Adam D.Chief Financial Officer1$15k

See ACRV on the chart

Every insider buy and sell for ACRV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.